Cabio Biotech (Wuhan) Co Ltd Sustainability Reports
The company develops, produces, and sells microbial-based nutritional ingredients, including arachidonic acid (ARA), docosahexaenoic acid (DHA), beta-carotene, and sialic acid, primarily for infant formula, dietary supplements, and animal nutrition.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00D8K8T15
2 reports from 2022 to 2022
